Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

More Time for Bayer-Topsun Deal

publication date: Mar 5, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Topsun Science and Technology (SHA: 600771) has agreed to extend the deadline for the giant German pharmaceutical company Bayer AG (XE: 575200) to close its 1.26 billion RMB ($177 million) purchase of Topsun’s portfolio of OTC cold drugs. Bayer must now complete the purchase by June 30, 2008. When the acquisition had not closed in February 2008, Topsun announced Bayer was in danger of losing the deal, but a new agreement was signed on February 29, extending the deadline for four months. It is not clear what is keeping Bayer from completing the purchase. More details...

Stock Symbols:  (SHA: 600771) (XE: 575200)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners